Sign inJoin waitlistJoin the waitlist

Andrew Yeager

Professor Emeritus, Medicine · University of Arizona College of Medicine-Tucson

Credentials: · ·

History

University of Arizona College of Medicine-Tucson
Present

Hematology and Medical Oncology
Johns Hopkins University School of Medicine
1978–1981
Johns Hopkins University School of Medicine
1975–1978
Johns Hopkins School of Medicine
1971–1975

Research

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide
New England Journal of Medicine · 1986 · First of over 10 authors · 553 citations
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from…
Blood · 2000 · 487 citations
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
Blood · 2014 · 285 citations

RS
Rein Saral
14 papers
JW
John Wingard
13 papers
HB
Hayden Braine
9 papers
JW
Joseph Wiley
9 papers
Rainer Storb
8 papers
SR
Scott Rowley
8 papers
Edmund Waller
6 papers
Michael Boyer
6 papers
MM
Michael Maris
6 papers
BB
Benedetto Bruno
5 papers
Brenda Sandmaier
5 papers
David Maloney
5 papers

Grants

Pentostatin and Alemtuzumab for Allogeneic PBPCT
National Cancer Institute · R21
Contact PI · $524.5K · University of Arizona
2004–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $134.9K · University of Pittsburgh at Pittsburgh
2005–2006
Pediatric Oncology Group
National Cancer Institute · U10
Contact PI · $1.6M · Emory University
1978–2002
Ex vivo Pharmacologic Purging in Rat Leukemia
National Cancer Institute · R01
Contact PI · $1.7M · Emory University
1987–1998

Clinical trials

Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States
Principal investigator · Completed · Phase 2
University of Arizona
2009–2016
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
Principal investigator · Completed · Phase 2
University of Arizona
2008–2016
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation
Principal investigator · Terminated · Phase 2
University of Arizona
2006–2011